AT
AGN

Arden Trust’s Allergan plc AGN Stock Holding History

Arden Trust’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,870
Closed -$2.28M – 827
2020
Q1 		$2.28M Sell
12,870
-375
-3% -$70.6K 0.45% 34
2019
Q4 		$2.53M Sell
13,245
-995
-7% -$179K 0.4% 52
2019
Q3 		$2.4M Sell
14,240
-1,916
-12% -$312K 0.39% 48
2019
Q2 		$2.71M Buy
16,156
+201
+1% +$27.8K 0.46% 41
2019
Q1 		$2.34M Buy
15,955
+2,904
+22% +$421K 0.38% 48
2018
Q4 		$1.75M Sell
13,051
-3,347
-20% -$549K 0.31% 64
2018
Q3 		$3.12M Sell
16,398
-235
-1% -$43.2K 0.49% 35
2018
Q2 		$2.77M Sell
16,633
-2,016
-11% -$324K 0.44% 43
2018
Q1 		$3.14M Buy
+18,649
New +$3.13M 0.49% 41
2017
Q4 		– Sell
-13,185
Closed -$2.7M – 371
2017
Q3 		$2.7M Sell
13,185
-52
-0.4% -$12.1K 0.41% 47
2017
Q2 		$3.22M Sell
13,237
-55
-0.4% -$12.9K 0.49% 38
2017
Q1 		$3.18M Buy
13,292
+159
+1% +$37K 0.5% 41
2016
Q4 		$2.76M Buy
13,133
+4,037
+44% +$836K 0.42% 47
2016
Q3 		$2.1M Sell
9,096
-27,722
-75% -$6.77M 0.32% 63
2016
Q2 		$8.51K Buy
36,818
+12,838
+54% +$2.96M 0.64% 41
2016
Q1 		$6.43M Buy
23,980
+827
+4% +$237K 0.51% 53
2015
Q4 		$7.24M Buy
23,153
+314
+1% +$93.5K 0.61% 43
2015
Q3 		$6.21M Buy
22,839
+6,815
+43% +$2.09M 0.51% 48
2015
Q2 		$4.86K Sell
16,024
-106
-0.7% -$31.6K 0.73% 35
2015
Q1 		$4.8K Buy
16,130
+7,892
+96% +$2.25M 0.7% 37
2014
Q4 		$2.12M Sell
8,238
-643
-7% -$161K 0.29% 73
2014
Q3 		$2.14M Buy
+8,881
New +$1.99M 0.29% 71

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Arden Trust's AGN Position: Q2 2020 in Review

Arden Trust sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 12,870 shares — an estimated $2.28M sold.

Arden Trust first reported a position in AGN in Q3 2014 and held it in 22 quarters. The position peaked at $7.24M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Arden Trust reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Arden Trust sold 12,870 Allergan plc shares in Q2 2020, an estimated $2.28M.
  • Arden Trust first reported a position in Allergan plc in Q3 2014 and held it in 22 quarters.
  • Arden Trust's Allergan plc position peaked at $7.24M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Arden Trust's 13F filing for Q2 2020, filed 9 Jul 2020.